Sil­i­con Val­ley Bank shut­ters; Rare dis­ease tri­als can't find enough pa­tients; FDA ad­comm votes in fa­vor of Po­livy la­bel ex­pan­sion; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

As a re­minder, we’re col­lect­ing nom­i­na­tions for our an­nu­al 20 un­der 40 and LGBTQ+ fea­tures. The dead­lines are March 23 and March 16, re­spec­tive­ly, so be sure to sub­mit your nom­i­na­tions!

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.